ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Sutro Biopharma, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -175.08% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -19.58
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 178.13%, its profits have fallen by -21.8%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.94% over the previous quarter and currently hold 9.24% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sutro Biopharma, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sutro Biopharma, Inc.
178.13%
0.41
1102.31%
S&P 500
16.12%
0.84
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.22%
EBIT Growth (5y)
-175.08%
EBIT to Interest (avg)
-19.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.97
Sales to Capital Employed (avg)
0.49
Tax Ratio
0.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-4.41
EV to EBIT
-3.19
EV to EBITDA
-3.37
EV to Capital Employed
-11.75
EV to Sales
4.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
NET SALES(HY)
Higher at USD 73.44 MM
NET PROFIT(HY)
Higher at USD -40.38 MM
RAW MATERIAL COST(Y)
Fallen by -1.95% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 19.98 times
-7What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -222.53 MM
INTEREST(9M)
At USD 28.66 MM has Grown at 28.07%
ROCE(HY)
Lowest at -1,810.01%
CASH AND EQV(HY)
Lowest at USD 372.73 MM
Here's what is working for Sutro Biopharma, Inc.
Net Sales
At USD 73.44 MM has Grown at 114.57%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Sales
Higher at USD 73.44 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Net Profit
Higher at USD -40.38 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -40.38 MM has Grown at 60.26%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Debtors Turnover Ratio
Highest at 19.98 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -1.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sutro Biopharma, Inc.
Interest
At USD 28.66 MM has Grown at 28.07%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Cash Flow
Lowest at USD -222.53 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Cash and Eqv
Lowest at USD 372.73 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
